Position in TRLV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$208,828
New position
Shares Held
21,244
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $49,855,783 across 32 Drug Manufacturers - Specialty & Generic names. TRLV ranks #18 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
171,031 | $12,290,287 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
337,688 | $11,707,642 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
131,451 | $4,453,559 | |
| 4 | AQST |
Aquestive Therapeutics, Inc.
|
1,046,175 | $4,352,088 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
5,205 | $2,820,225 | |
| 6 | VTRS |
Viatris Inc
|
174,057 | $2,764,025 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
15,270 | $2,573,605 | |
| 8 | HLN |
Haleon plc
|
195,825 | $1,827,047 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,828 | 21,244 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||